2,234
Views
4
CrossRef citations to date
0
Altmetric
Articles

Health Reform and the Substance Use Disorder Treatment System: A Time of Change

, M.D., J.D., M.P.H.
Pages 91-94 | Received 31 Mar 2017, Accepted 31 Mar 2017, Published online: 02 Jun 2017

References

  • Aletraris, L., M. B. Edmond, and P. M. Roman. 2017. Insurance receipt and readiness for opportunities under the Affordable Care Act: A national survey of treatment providers for substance use disorders. Journal of Psychoactive Drugs 49 (2):141–50. doi:10.1080/02791072.2017.1306661
  • Aletraris, L., P. M. Roman, and J. Pruett. 2017. Integration of care in the implementation of the Affordable Care Act: Changes in treatment services in a national sample of centers treating substance use disorders. Journal of Psychoactive Drugs 49 (2):132–40. doi:10.1080/02791072.2017.1299263.
  • Danovitch, I., and D. Kan. 2017. The addiction benefits scorecard: A framework to promote health insurer accountability and support consumer engagement. Journal of Psychoactive Drugs 49 (2):122–31. doi:10.1080/02791072.2017.1296210.
  • Frank, R. G., and H. A. Pollack. 2017. Addressing the fentanyl threat to public health. New England Journal of Medicine 376 (7):605–07. doi:10.1056/NEJMp1615145.
  • Healthcare.gov. n.d. The “metal” categories: Bronze, silver, gold & platinum. https://www.healthcare.gov/search/?q=metal%20plans (accessed April 15, 2017).
  • Knudsen, H. K., M. R. Lofwall, J. R. Havens, and S. L. Walsh. 2015. States’ implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug and Alcohol Dependence 157:36–43. doi:10.1016/j.drugalcdep.2015.09.032.
  • Knudsen, H. K., and J. L. Studts. 2017. Perceived impacts of the Affordable Care Act: Perspectives of buprenorphine prescribers. Journal of Psychoactive Drugs 49 (2):111–21. doi:10.1080/02791072.2017.1295335.
  • Quinn, A. E., M. T. Stewart, M. Brolin, C. Horgan, and N. E. Lane. 2017. Massachusetts substance use disorder treatment organizations’ perspectives on the Affordable Care Act: Changes in payment, services, and system design. Journal of Psychoactive Drugs 49 (2):151–59. doi:10.1080/02791072.2017.1301600.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). n.d. National Survey on Drug Use and Health, 2014 and 2015 (Table 1.23A). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.pdf (accessed May 2, 2017).
  • Smith, D. E. 2017. Medicalizing the opioid epidemic in the U.S. in the era of health care reform. Journal of Psychoactive Drugs 49 (2):95–101. doi:10.1080/02791072.1983.10472116.
  • The White House. 2017. Presidential executive order establishing the President's Commission on Combating Drug Addiction and The Opioid Crisis. https://www.whitehouse.gov/the-press-office/2017/03/30/presidential-executive-order-establishing-presidents-commission ( accessed May 2, 2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.